|
|
|
51-200 employees
View all
|
|
Pharmaceuticals
|
|
STE: 1401,New York,NY,US
|
|
Nuvation Bio | 1,660 followers on LinkedIn. Nuvation Bio is focused on treating the most difficult-to-treat cancers, for which conventional therapies have failed. | Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines.
|
Nuvation Bio Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Nuvation Bio email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Nuvation Bio customer service number in your country click here to find.
David Hung is the CEO of Nuvation Bio. To contact David Hung email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.